Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 22:00:00
Envoy Med Rg-A (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
0,60 14,44 0,08 307 223
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiEnvoy Medical Inc
TickerCOCH
Kmenové akcie:Ordinary Shares Class A
RICCOCH.O
ISIN-
Prioritní akciePreference Shares
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 42
Akcie v oběhu k 10.11.2025 28 786 511
MěnaUSD
Kontaktní informace
Ulice4875 White Bear Parkway
MěstoWHITE BEAR LAKE
PSČ55110
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon16 513 618 000

Business Summary: Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Envoy Medical Inc revenues decreased 9% to $166K. Net loss applicable to common stockholders increased 3% to $20.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Advanced Medical Equipment & Technology segment loss increase of 8% to $15.9M.
Odvětvová klasifikace
TRBC2012Advanced Medical Equipment & Technology (NEC)
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Trusts, Estates, and Agency Accounts
NAICS1997Trusts, Estates, and Agency Accounts
SICElectromedical Equipment



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, DirectorBrent Lucas4323.06.202529.09.2023
Interim Chief Financial OfficerRobert Potashnick4523.06.202523.06.2025